Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/26591
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBroadley, S.-
dc.contributor.authorWiendl, Heinz-
dc.contributor.authorFernandez, O.-
dc.contributor.authorFreedman, M. S.-
dc.contributor.authorIzquierdo, G.-
dc.contributor.authorLycke, J.-
dc.contributor.authorPozzilli, C.-
dc.contributor.authorSharrack, B.-
dc.contributor.authorSinger, B. A.-
dc.contributor.authorSteingo, B.-
dc.contributor.authorVermersch, P.-
dc.contributor.authorWray, S.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorZiemssen, T.-
dc.contributor.authorMargolin, D. H.-
dc.contributor.authorThangavelu, K.-
dc.contributor.authorBoster, A.-
dc.date.accessioned2018-08-06T09:45:48Z-
dc.date.available2018-08-06T09:45:48Z-
dc.date.issued2018-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 24(3), p. 399-399 (Art N° P-53)-
dc.identifier.issn1352-4585-
dc.identifier.urihttp://hdl.handle.net/1942/26591-
dc.language.isoen-
dc.titleLong-term Improvement in Clinical Outcomes in Alemtuzumab-Treated RRMS Patients Who Relapsed Between Courses 1 and 2 (CARE-MS I)-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateNOV 23-25, 2017-
local.bibliographicCitation.conferencename10th Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS)-
local.bibliographicCitation.conferenceplaceHo Chi Minh City, VIETNAM-
dc.identifier.epage399-
dc.identifier.issue3-
dc.identifier.spage399-
dc.identifier.volume24-
local.bibliographicCitation.jcatM-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrP-53-
dc.identifier.doi10.1177/1352458517751792-
dc.identifier.isi000429327000112-
item.fulltextWith Fulltext-
item.contributorBroadley, S.-
item.contributorWiendl, Heinz-
item.contributorFernandez, O.-
item.contributorFreedman, M. S.-
item.contributorIzquierdo, G.-
item.contributorLycke, J.-
item.contributorPozzilli, C.-
item.contributorSharrack, B.-
item.contributorSinger, B. A.-
item.contributorSteingo, B.-
item.contributorVermersch, P.-
item.contributorWray, S.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorZiemssen, T.-
item.contributorMargolin, D. H.-
item.contributorThangavelu, K.-
item.contributorBoster, A.-
item.fullcitationBroadley, S.; Wiendl, Heinz; Fernandez, O.; Freedman, M. S.; Izquierdo, G.; Lycke, J.; Pozzilli, C.; Sharrack, B.; Singer, B. A.; Steingo, B.; Vermersch, P.; Wray, S.; VAN WIJMEERSCH, Bart; Ziemssen, T.; Margolin, D. H.; Thangavelu, K. & Boster, A. (2018) Long-term Improvement in Clinical Outcomes in Alemtuzumab-Treated RRMS Patients Who Relapsed Between Courses 1 and 2 (CARE-MS I). In: MULTIPLE SCLEROSIS JOURNAL, 24(3), p. 399-399 (Art N° P-53).-
item.accessRightsRestricted Access-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
P-5.pdf
  Restricted Access		Published version63.99 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.